According to The Guardian, the Bank Policy Institute (BPI), representing 40 major U.S. banks including JPMorgan Chase, Goldman Sachs, and Citigroup, is considering suing the Office of the Comptroller of the Currency (OCC) for failing to heed multiple warnings from the banking industry regarding the loosening of federal licensing rule interpretations.
Under the leadership of Jonathan Gould, a former crypto executive appointed by Trump, the OCC has effectively lowered the threshold for cryptocurrency and fintech companies to obtain national bank trust charters, allowing them to serve customers in all 50 states. The banking sector believes this move enables crypto companies to enter the financial system without strict regulation, blurring the lines of "banking" and increasing systemic risk. Last year, the BPI urged the OCC to reject license applications from companies like Circle and Ripple. The organization has not yet made a final decision on whether to proceed with the lawsuit.
This content is provided for general informational purposes only and doesn't constitute financial, investment, legal, or tax advice. Any events, rewards, online promotions, or related information mentioned herein should not be considered a recommendation, solicitation, or invitation to purchase, sell, trade, or otherwise deal in any crypto assets. Crypto assets are highly volatile and may result in loss. The availability of WEEX services, products, and related events may vary by region. You are responsible for ensuring that your participation is in accordance with applicable local laws and regulations.




Key Takeaways Hong Kong aims to integrate its debt market into the blockchain era, launching a platform for…

Key Takeaways Hong Kong is pioneering the integration of its debt market with blockchain technology through a new…

Key Takeaways: A group of senior UK lawmakers is pushing for a legislative ban on political donations in…


Key Takeaways UBS partners with Ant International to pioneer tokenized deposits for real-time cross-border payments and liquidity management.…

Moderna shares more than doubled on 19 August 2026 after Merck and Moderna said the Phase 3 INTerpath-001 trial of intismeran autogene plus KEYTRUDA met its recurrence-free survival endpoint in resected melanoma. This page explains what the result is, why the stock reacted this hard, what is still unknown, which dates come next (presentation and earnings, both unconfirmed), and what a trader can actually do on WEEX — which does not list Moderna; the nearest instrument is the XBI-USDT biotech ETF perpetual. No price targets, no forecasts.















Long-end U.S. Treasury yields surged to multi-year highs, pressuring technology, semiconductor, storage, and optical communication stocks and driving a clear cooling in market risk appetite. At the same time, Anthropic’s revenue came in below some bullish expectations, prompting investors to reassess the AI growth narrative; Unitree Robotics officially listed on the STAR Market, extending momentum in robotics and embodied AI; while SpaceX and other commercial space names showed relative resilience. Investors are now focused on tonight’s Federal Reserve minutes for clearer signals on the policy path and broader market sentiment.






Key Takeaways Hong Kong aims to integrate its debt market into the blockchain era, launching a platform for…
Key Takeaways Hong Kong is pioneering the integration of its debt market with blockchain technology through a new…
Key Takeaways: A group of senior UK lawmakers is pushing for a legislative ban on political donations in…